Not Signed In -
Agent Orange |
|
|
For other uses, see Agent Orange (disambiguation). Vietnam. Defoliation Mission. A UH-1D helicopter from the 336th Aviation Company sprays a defoliation agent on a dense jungle area in the Mekong delta., July 26, 1969 Agent Orange was the nickname given to a powerful herbicide and defoliant used by the U.S. military in its Herbicidal Warfare program during the Vietnam War. Agent Orange was used from 1961 to 1971, and was by far the most used of the so-called "rainbow herbicides" us ...
Wikipedia - [full article]
Agent Orange Clinical Trials
- Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent Vs. Double-Agent Vs. Triple-Agent Therapy.
ClinicalTrials.gov Identifier: NCT00148395 - Active, not recruiting
Non-Small-Cell Lung Carcinoma
- Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.
ClinicalTrials.gov Identifier: NCT00547768 - Completed
Allergy
- The AOT (Acridine Orange and Taurolidine) Trial
ClinicalTrials.gov Identifier: NCT00321165 - Recruiting
Parenteral Nutrition; Infection; Sepsis
- Impact of Consumption of Orange-Fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age
ClinicalTrials.gov Identifier: NCT00453648 - Recruiting
Vitamin A Deficiency
- Tarceva® as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
ClinicalTrials.gov Identifier: NCT00294762 - Active, not recruiting
Carcinoma, Non-Small-Cell Lung
- Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma
ClinicalTrials.gov Identifier: NCT00456677 - Active, not recruiting
Asthma
- Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy
ClinicalTrials.gov Identifier: NCT00532415 - Active, not recruiting
Vitrectomy
- A Targeted Cytotoxic Investigational Agent Given to Patients with Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00104364 - Active, not recruiting
Cancer
- Efficacy and Safety Study to Evaluate Gadovist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients
ClinicalTrials.gov Identifier: NCT00395460 - Active, not recruiting
Central Nervous System Diseases
- Topical Agent for Treatment of Red Skin
ClinicalTrials.gov Identifier: NCT00279890 - Active, not recruiting
Rosacea; Bilaterally Symmetric Red Skin on Cheeks
- A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFα Agent(s)
ClinicalTrials.gov Identifier: NCT00299546 - Active, not recruiting
Arthritis, Rheumatoid
- Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
ClinicalTrials.gov Identifier: NCT00053599 - Active, not recruiting
Alzheimer Disease
- ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study
ClinicalTrials.gov Identifier: NCT00525577 - Recruiting
Diabetes
- A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-Line Treatment of Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00251472 - Active, not recruiting
Metastatic Breast Cancer
- Tolerability Study of Investigational Agent, ARRY-520, in Subjects With Cancer
ClinicalTrials.gov Identifier: NCT00462358 - Recruiting
Neoplasms
- Single Agent Alimta in Poor Performance Status in NSCLC
ClinicalTrials.gov Identifier: NCT00508144 - Recruiting
Lung Cancer
- Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
ClinicalTrials.gov Identifier: NCT00561496 - Recruiting
HIV Infections
- Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
Diabetes Mellitus, Type 2
- A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00461786 - Active, not recruiting
Ovarian Cancer; Peritoneal Cancer
- Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent
ClinicalTrials.gov Identifier: NCT00415805 - Recruiting
Steno-Occulsive Disease
- A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel
ClinicalTrials.gov Identifier: NCT00313456 - Recruiting
Tumors; Prostate Cancer
- Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or Lymphoma
ClinicalTrials.gov Identifier: NCT00322608 - Recruiting
Cancer
- A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
ClinicalTrials.gov Identifier: NCT00475917 - Recruiting
Cancer; Lymphoma
- Tolerability Study of Investigational Agent, ARRY-142886, in Patients with Cancer
ClinicalTrials.gov Identifier: NCT00085787 - Active, not recruiting
Cancer
- Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
ClinicalTrials.gov Identifier: NCT00398879 - Recruiting
Soft Tissue Sarcoma
- Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor
ClinicalTrials.gov Identifier: NCT00454649 - Recruiting
Neoplasms
- Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
ClinicalTrials.gov Identifier: NCT00092937 - Active, not recruiting
Granulomatous Disease; Chronic
- Anti-angiogenesis Agent AG-013736 in Patients with Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00094107 - Active, not recruiting
Melanoma; Metastases
- Safety and efficacy of single-agent CC-5013 in subjects with relapsed and refractory multiple myeloma
ClinicalTrials.gov Identifier: NCT00065351 - Active, not recruiting
Multiple Myeloma
- Taurine as an Anti-Manic Agent.
ClinicalTrials.gov Identifier: NCT00217165 - Recruiting
Bipolar Disorder; Mania; Bipolar Depression
- Tolerability Study of Investigational Agent, ARRY-334543, in Patients With Cancer
ClinicalTrials.gov Identifier: NCT00278902 - Recruiting
Cancer
- Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00313248 - Recruiting
Breast Neoplasm
- Safety Study of Anti-Asthma Agent BMEC-1217B
ClinicalTrials.gov Identifier: NCT00425971 - Recruiting
Asthma
- Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
ClinicalTrials.gov Identifier: NCT00401960 - Recruiting
Endocarditis, Bacterial
- A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
ClinicalTrials.gov Identifier: NCT00215956 - Recruiting
Rectal Neoplasms
- Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
ClinicalTrials.gov Identifier: NCT00495872 - Recruiting
Advanced Cancer
- Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer
ClinicalTrials.gov Identifier: NCT00040430 - Active, not recruiting
Breast Cancer
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00484276 - Recruiting
Mesothelioma
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.
ClinicalTrials.gov Identifier: NCT00160043 - Active, not recruiting
Non Small Cell Lung Cancer
- A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-Agent Constituents for Treatment of Obesity in Adults
ClinicalTrials.gov Identifier: NCT00563368 - Recruiting
Obesity
- A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent
ClinicalTrials.gov Identifier: NCT00336973 - Recruiting
Psoriasis
- Study of the Anti-angiogenesis Agent AG-013736 in Patients with Metastatic Thyroid Cancer
ClinicalTrials.gov Identifier: NCT00094055 - Active, not recruiting
Thyroid Cancer; Metastases
- Multi-Dose-Escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-Cell Non Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00549185 - Recruiting
Lymphoma; Non-Hodgkin
- A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.
ClinicalTrials.gov Identifier: NCT00381212 - Recruiting
HIV Seropositivity; Acquired Immunodeficiency Syndrome
- Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00429416 - Recruiting
Hematological Malignancies
- CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
ClinicalTrials.gov Identifier: NCT00514345 - Recruiting
Chemotherapeutic Agent Toxicity; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
- Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent
ClinicalTrials.gov Identifier: NCT00334945 - Recruiting
Growth Disorders
- A Phase 2 Study of Single Agent EKB-569 in Subjects with Advanced Colorectal Cancer.
ClinicalTrials.gov Identifier: NCT00072748 - Active, not recruiting
Colorectal Cancer
- Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent
ClinicalTrials.gov Identifier: NCT00361036 - Recruiting
Leiomyoma; Leiomyomatosis; Uterine Neoplasms
- Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
ClinicalTrials.gov Identifier: NCT00486213 - Recruiting
Chemotherapeutic Agent Toxicity; Dermatologic Complications; Palmar-Plantar Erythrodysesthesia; Unspecified Adult Solid Tumor, Protocol Specific
- Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00391001 - Recruiting
Bipolar Disorder
- Safety Study of Gene Transfer Agent MYDICAR™ (AAV1/SERCA2a) to Treat Heart Failure
ClinicalTrials.gov Identifier: NCT00454818 - Recruiting
Heart Failure, Congestive
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov Identifier: NCT00484211 - Recruiting
Hepatocellular Carcinoma
- Safety and Efficacy Study of FLT Radiolabeled Imaging Agent With PET Scan in Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00572728 - Recruiting
Breast Cancer
- Single Agent Erlotinib in Chemotherapy-Naive Androgen Independent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00272038 - Recruiting
Prostate Cancer
- Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
ClinicalTrials.gov Identifier: NCT00285727 - Recruiting
Major Depression
- Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence
ClinicalTrials.gov Identifier: NCT00333073 - Recruiting
Urinary Incontinence
- A New Agent DAVANAT in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00388700 - Recruiting
Colorectal Cancer
- Memantine as an Adjunctive Agent to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Severe Major Depressive Episode
ClinicalTrials.gov Identifier: NCT00186498 - Recruiting
Major Depressive Disorder
- Treatment of Patients with Locally Advanced and Metastatic Pancreatic Adenocarcinoma with the Single Agent MDX-010 (anti-CTLA4)
ClinicalTrials.gov Identifier: NCT00108888 - Recruiting
- Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-Untreated Follicular Lymphoma (FL)
ClinicalTrials.gov Identifier: NCT00427856 - Recruiting
Lymphoma, Follicular
- Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00543972 - Recruiting
Myeloid Leukemia
- Efficacy and Safety Study to Evaluate Gadovist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
ClinicalTrials.gov Identifier: NCT00395733 - Recruiting
Vascular Diseases
- A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
ClinicalTrials.gov Identifier: NCT00476827 - Recruiting
Breast Cancer
- Study of CMC-544 Administered as a Single Agent in Subjects With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00073749 - Active, not recruiting
Lymphoma, Non-Hodgkin's; B-Cell Lymphoma
- Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
ClinicalTrials.gov Identifier: NCT00499798 - Recruiting
Brain and Central Nervous System Tumors; Chemotherapeutic Agent Toxicity; Sexual Dysfunction and Infertility
- Study of NGR-hTNF as Single Agent in Patients Affected by Metastatic Small Cell Lung Carcinoma
ClinicalTrials.gov Identifier: NCT00483509 - Recruiting
Small Cell Lung Cancer
- Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Doxorubicin
ClinicalTrials.gov Identifier: NCT00577798 - Recruiting
Cardiac Toxicity; Chemotherapeutic Agent Toxicity; Lymphoma
- Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients
ClinicalTrials.gov Identifier: NCT00132223 - Recruiting
vessel
- Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00517712 - Recruiting
Acute Promyelocytic Leukemia
- Hydralazine as a Demethylating Agent in Rectal Cancer
ClinicalTrials.gov Identifier: NCT00575640 - Recruiting
Rectal Cancer
- Hydralazine as Demethylating Agent in Breast Cancer
ClinicalTrials.gov Identifier: NCT00575978 - Recruiting
Breast Cancer
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00288249 - Recruiting
Metastatic Breast Cancer
- Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent
ClinicalTrials.gov Identifier: NCT00329316 - Not yet recruiting
Pregnancy; Premature Birth
- A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00359359 - Recruiting
Small Cell Lung Cancer
- Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent with Metastatic Lung Cancer
ClinicalTrials.gov Identifier: NCT00040560 - Active, not recruiting
Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Brain Neoplasms; Metastases, Neoplasm
- A Phase II Study of Oral CC-5013 Lenalidomide (Revlimid), an Antiangiogenic and Immunomodulatory Agent, in Patients with Stage IV Ocular Melanoma
ClinicalTrials.gov Identifier: NCT00109005 - Recruiting
- A Phase II Single Arm Trial of Single-Agent Vinflunine as Second-Line Treatment of Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00251446 - Recruiting
Non-Small Cell Lung Cancer
- Effect of Pioglitazone
ClinicalTrials.gov Identifier: NCT00232362 - Recruiting
Type 2 Diabetes Mellitus
- PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION
ClinicalTrials.gov Identifier: NCT00130598 - Recruiting
Contrast Media; Renal Dysfunction
- CNF2024 as Single-Agent Treatment in Subjects With HER2‑ Advanced Breast Cancer or in Combination With Trastuzumab in Subjects With HER2+ Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00412412 - Recruiting
Breast Cancer
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-Small-Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00160069 - Recruiting
Non Small Cell Lung Carcinoma
- Chemotherapy and Radiation Therapy With or Without Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00503776 - Recruiting
Chemotherapeutic Agent Toxicity; Dysphagia; Head and Neck Cancer; Mucositis; Radiation Toxicity; Xerostomia
- Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair
ClinicalTrials.gov Identifier: NCT00520416 - Recruiting
Carbon Dioxide; Endovascular Abdominal Aortic Aneurym Repair; Prospective; Angiogram
- A Phase I Study of Single Agent OSI-774 (Tarceva ) Followed by OSI-774 with Temozolomide for Patients with Selected Recurrent/Refractory Solid Tumors, including Brain Tumors
ClinicalTrials.gov Identifier: NCT00089934 - Recruiting
Neoplasms
- ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00312377 - Recruiting
Non-Small Cell Lung Cancer; Lung Cancer
- Comparison of Pregabalin Versus Comparative Agent and Placebo in the Treatment of Generalized Anxiety Disorder
ClinicalTrials.gov Identifier: NCT00151450 - Completed
Anti-Anxiety Agents
- PF-00299804 as a Single Agent, in Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy.
ClinicalTrials.gov Identifier: NCT00548093 - Not yet recruiting
Carcinoma, Non Small Cell Lung
- A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
ClinicalTrials.gov Identifier: NCT00336310 - Not yet recruiting
Diabetes Mellitus, Type 2
- A Single Agent Phase II Study of Depsipeptide (FK228) in the Treatment of Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00106431 - Recruiting
Cutaneous T-Cell Lymphoma
- The Assessment of a weight-gain agent for the Treatment of Olanzapine-Associated Anti-obesity Agent in Patients with Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00044187 - Completed
Schizophrenia; Psychotic Disorders; Bipolar Disorder
- A Trial o Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy.
ClinicalTrials.gov Identifier: NCT00250263 - Not yet recruiting
Allergic Rhinitis; Asthma
- MRI in Staging Ovarian Cancer Using MRI Contrast Agent
ClinicalTrials.gov Identifier: NCT00463996 - Not yet recruiting
Ovarian Cancer
- Ethyol (Amifostine) Cytoprotective Agent/Bone Marrow Sparing Agent
ClinicalTrials.gov Identifier: NCT00130143 - Completed
Head and Neck Cancer; Lung Cancer
- Evaluation of Vitrase as a Spreading Agent
ClinicalTrials.gov Identifier: NCT00198484 - Completed
Pain
- Topical Gel Anti-Fungal Agent for Tinea Unguium
ClinicalTrials.gov Identifier: NCT00253305 - Completed
Onychomycosis
- A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
ClinicalTrials.gov Identifier: NCT00264433 - Completed
Neoplasms
- To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections
ClinicalTrials.gov Identifier: NCT00397956 - Completed
Sepsis
- Phase 1 Study of Anti-Glycation Agent GLY-230 in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00544921 - Completed
Diabetes
- The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis(ISAR-TEST-2)
ClinicalTrials.gov Identifier: NCT00332397 - Completed
Coronary Disease
Resources
- Agent Orange (National Women's Health Information Center)
- Agent Orange - Herbicide Exposure (Veterans Benefits Administration)
email this page
print this page
bookmark this page
feedback on this page
